Plain-English translation of NCT07239427 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether transcranial direct current stimulation (tDCS)—a non-invasive technique that uses mild electrical current to stimulate specific areas of the brain—can improve fibromyalgia pain relief when combined with a comprehensive pain management program. All participants will receive pain education classes and therapeutic exercise sessions, but half will also receive real brain stimulation while the other half receive a placebo version. The goal is to see if the real stimulation provides extra benefit beyond the education and exercise alone.
Fibromyalgia causes widespread, long-lasting pain that is difficult to treat with standard approaches. Researchers believe this medication may help by changing how the brain processes pain signals, and this trial will determine whether adding it to an existing pain management program makes a meaningful difference for patients.
You likely qualify if…
You likely don't qualify if…
Over several weeks, you will attend 31 sessions total. First, you'll complete 8 classes learning about how pain works in your body and strategies to manage it. Next, you'll receive 5 daily sessions of either real or placebo brain stimulation (each about 20 minutes), where small electrodes are placed on your scalp. Finally, you'll complete 18 sessions of guided therapeutic exercise. Throughout the study, you'll answer questions about your pain levels and how you're functioning, helping researchers understand whether the brain stimulation adds extra benefit to the education and exercise program.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Spain